Identification of antimicrobial activity among FDA-approved drugs for combating Mycobacterium abscessus and Mycobacterium chelonae

The challenge of new drug discovery for tuberculosis

(2011) Anil Koul et al.   NATURE

Synthesis, anticonvulsant and antimicrobial activities of some new 2-acetylnaphthalene derivatives

(2010) Arzu Karakurt et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Antibiotic susceptibility pattern of rapidly growing mycobacteria

(2010) LilyK Therese et al.   Journal of Postgraduate Medicine

Synthesis, spectroscopic and thermal characterization of sulpiride complexes of iron, manganese, copper, cobalt, nickel, and zinc salts. Antibacterial and antifungal activity

(2010) Gehad G. Mohamed et al.   SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY

Daptomycin is not active against rapidly growing mycobacteria

(2009) S. Bastian et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Molecular Cloning, Characterization, and Inhibition Studies of the Rv1284 β-Carbonic Anhydrase fromMycobacterium tuberculosiswith Sulfonamides and a Sulfamate

(2009) Tomoko Minakuchi et al.   JOURNAL OF MEDICINAL CHEMISTRY

Repurposing with a Difference

(2009) M. S. Boguski et al.   SCIENCE

New anti-tuberculosis agents amongst known drugs

(2009) Kathryn E.A. Lougheed et al.   TUBERCULOSIS